Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.38M | 2.16M | 1.94M | 2.20M | 2.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38M | 2.16M | 1.94M | 2.20M | 2.46M |
| Cost of Revenue | 195.40K | 239.80K | 284.20K | 297.60K | 311.00K |
| Gross Profit | 2.19M | 1.92M | 1.66M | 1.90M | 2.15M |
| SG&A Expenses | 1.36M | 1.19M | 1.02M | 980.70K | 936.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.59M | 1.47M | 1.34M | 1.31M | 1.28M |
| Operating Income | 793.80K | 696.00K | 598.20K | 889.40K | 1.18M |
| Income Before Tax | 793.40K | 695.30K | 597.20K | 889.40K | 1.18M |
| Income Tax Expenses | 314.80K | 255.50K | 196.20K | 262.90K | 329.60K |
| Earnings from Continuing Operations | 0.48 | 0.44 | 0.40 | 0.63 | 0.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 478.60K | 439.90K | 401.20K | 626.60K | 852.00K |
| EBIT | 793.80K | 696.00K | 598.20K | 889.40K | 1.18M |
| EBITDA | 816.40K | 717.90K | 619.40K | 910.00K | 1.20M |
| EPS Basic | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Average Basic Shares Outstanding | 100.00M | 100.00M | 100.00M | 100.00M | 100.00M |
| Average Diluted Shares Outstanding | 100.00M | 100.00M | 100.00M | 100.00M | 100.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |